Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Watch How Eli Lilly's CEO Plans to Defeat Pharma's Boom-Bust Cycle
When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege. Americans held drug companies in lower esteem than airlines, law firms and even the federal government. President Donald Trump, then…
Shifting Frontiers: How Clinical Milestones and Corporate Realities Are Shaping the 2026 Pharma Landscape
As the pharmaceutical sector navigates the midpoint of 2026, capital allocation strategies are highlighting a fascinating divergence between broad-scale oncology bets and highly targeted micro-caps solving specific cellular riddles. While the war…
Honasa Consumer to acquire 58% stake in Fluence Pharma
Honasa Consumer Ltd, on Tuesday said it will acquire 58 per cent stake in Fluence Pharma, which is a science-backed nutraceuticals company. This marks the beauty and personal care company's entry in the rapidly growing nutraceuticals space In a BSE…
Billionaire French pharma heir leaves riches to mystery charity
LUXEMBOURG CITY - One of the billionaire heirs behind French drugmaker Ipsen SA has left his US$4 billion (S$5.2 billion) fortune to a Luxembourg charity and an offshore trust, clouding the outlook for the company's long-term control and ownership.
Honasa shares slip 3% after it announces acquisition of nutraceuticals maker Fluence Pharma
Shares of Honasa Consumer Ltd fell 3.07 per cent to ₹407 on Wednesday on the NSE, a day after the Mamaearth parent announced the acquisition of a majority 58 per cent stake in science-backed nutraceuticals company Fluence Pharma Private Ltd.
IT selloff drags Nifty below 24,000; pharma stocks buck the trend
Markets turned sharply lower by midday on Tuesday, with the Nifty 50 slipping below the crucial 24,000 mark after early consolidation gave way to heavy selling in information technology and metals. At 12.35 pm, the Sensex was trading at 76,569.98…
Teleo Capital scoops up pharma manufacturing intelligence platform Modersys
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
India's pharma supply chain heavily dependent on Chinese imports: NITI Aayog
India's pharmaceutical supply chain remains heavily dependent (65 per cent) on Chinese imports for critical active pharmaceutical ingredient (APIs) and key starting materials, NITI Aayog said on Tuesday. The Aayog, in its eighth edition of 'Trade…
Markets go into a tailspin, Sensex tanks 893 points
Stock market benchmark indices Sensex and Nifty faced heavy selling pressure on Tuesday, dropping over 1 per cent, tracking a bearish trend in global markets along with weakness in HDFC Bank and IT firms. Fresh foreign fund outflows also led to the…
Stock markets turn flat in subdued trading
Stock market benchmark indices Sensex and Nifty were trading flat in a subdued trading on Tuesday, as investors stayed on the sidelines after the recent rally. Weak trends in Asian markets and fresh foreign fund outflows also led to the subdued…
China is fretting over a demographic crisis - but what companies might benefit?
As China moves towards becoming one of the world's fastest-ageing economies – a trend causing worry over future productivity and a widening gulf between the country's working and retired populations – Goldman Sachs said the…
Fund manager names 3 stocks for investors who want to rotate out of AI
Global tech stocks are selling off, with European equities following their Asian and U.S. peers into the red. Chip stocks are leading the declines in Europe. In U.S. pre-market trade, Intel and Micron are coming under pressure. Speaking to CNBC…
Indian Stock Market Plunge: Sensex, Nifty Drop Over 1% on Global Sell-off, IT Weakness, FII Outflows
Indian stock markets, including the Sensex and Nifty, witnessed a significant decline of over 1 per cent, mirroring a bearish global trend and exacerbated by weakness in key sectors like IT and substantial foreign fund outflows. The BSE Sensex…
Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities
After lagging expectations during recent market volatility, the healthcare sector is showing signs of renewed strength. Jacky He, Vice President of Portfolio Research at TD Asset Management, explains what's driving the sector's rebound, the next…
China detains two Japanese nationals suspected of smuggling banned goods
China has detained two Japanese nationals suspected of smuggling banned goods, Tokyo said on Wednesday after media reported that an employee of a major Japanese electronics firm was among those arrested in a case involving rare earth-related…
Receive a Daily briefing on Pharma Industry News
Get Started